Prevalence of advanced fibrosis similar in lean, non-lean MA

WASHINGTON — The risk for advanced fibrosis was similar among patients with lean and non-lean metabolic dysfunction-associated steatotic liver disease and may be associated with genetic risk, according to data at Digestive Disease Week.
“There are conflicting studies on the severity of MASLD in patients with a normal BMI, termed lean MASLD, which is estimated to affect up to 10

Related Keywords

United States , California , San Diego , Washington , Americans , Bymonica Stonehill , Veeralh Ajmera , Heather Biele , Research Center , University Of California , Digestive Disease ,